Evigrade
DrugsCosmetic ingredientsCalculatorsInteractionsEvigrade SkinEvigrade Meds ↗
ConditionsJournalMethodologyPro for practitioners
ESRU

Tiotropium

AEMPS

Long-acting muscarinic antagonist for inhalation (LAMA)

ATC code: R03BB04

Brand names: Spiriva Respimat, Spiriva HandiHaler, Spiriva

Updated · Methodology

Indications

A

Chronic obstructive pulmonary disease

First line

Tiotropium is a first-line LAMA for COPD maintenance. 2024 and GesEPOC 2024 recommend LAMA monotherapy in group B; with frequent exacerbations a LABA is added (LABA+LAMA: Spiolto, Anoro) or triple therapy ICS+LABA+LAMA (Trelegy, Trimbow). The Cochrane 2018 network meta-analysis (Oba) showed comparable efficacy with aclidinium and umeclidinium for exacerbations and mortality.

Sources

  1. AEMPS: Ficha técnica de Tiotropio (Spiriva) (2023)
  2. GOLD: Global Strategy for Diagnosis, Management and Prevention of COPD (2024)
  3. Cochrane: Long-acting muscarinic antagonists (LAMA) versus long-acting beta-agonists (LABA) and other LAMAs in COPD: network meta-analysis (2018)

ICD-10: J44 · ICD-11: CA22

A

Severe asthma

Adjunct

Tiotropium Respimat is add-on therapy for severe asthma in adults and adolescents from age 6 when ICS+LABA fail to achieve control. 2024 positions tiotropium at steps 4–5 as an option before biologics. approved tiotropium Respimat for asthma in adults in 2014 and in children from age 6 in 2017. Marketing of tiotropium in mild asthma or in children under 6 is off-label without RCT support.

Sources

  1. AEMPS: Ficha técnica de Tiotropio (Spiriva) (2023)
  2. GINA: Global Strategy for Asthma Management and Prevention (2024)
  3. GEMA: Guia Espanola para el Manejo del Asma (GEMA 5.4) (2024)

ICD-10: J45.9 · ICD-11: CA23.3

Marketing claims without evidence base

The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.

F

Athletic endurance

Not recommended

Tiotropium is offered off-label as a «training bronchodilator» without a COPD or asthma diagnosis. In healthy individuals there is no meaningful FEV1 gain: bronchodilation provides benefit only when baseline obstruction is present. WADA does not prohibit tiotropium, but use without a diagnosis means unjustified chronic anticholinergic exposure: dry mouth, urinary retention, raised intraocular pressure in susceptible patients. Beers Criteria 2023 lists inhaled LAMAs among anticholinergic-burden drugs in older adults. If tiotropium is suggested to «boost breathing capacity» without obstructive disease, consider seeking a second opinion.

Sources

  1. AEMPS: Ficha técnica de Tiotropio (Spiriva) (2023)
  2. AGS: American Geriatrics Society 2023 Updated AGS Beers Criteria (2023)
F

Immune support and respiratory infection care

Not recommended

Tiotropium is a long-acting inhaled antimuscarinic (LAMA). It is prescribed for COPD and severe asthma as add-on therapy ( 2024, 2024). Tiotropium is used in inhaler form for enhanced breathing and exercise-related breathing difficulty outside a COPD or severe asthma indication. No clinical studies of prophylactic use in this setting exist. The drug causes dry mouth, urinary retention (especially in men with benign prostatic hyperplasia), and elevated intraocular pressure (especially in angle-closure glaucoma). If tiotropium was prescribed outside confirmed COPD or severe asthma, consider seeking a second opinion.

Sources

  1. AEMPS: Ficha técnica de Tiotropio (Spiriva) (2023)
  2. Cochrane (Hemila and Chalker): Vitamin C for preventing and treating the common cold (2013)
How to read tiers A–F
  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit

Mechanism of action

Competitive antagonist at muscarinic M1–M5 receptors with slow dissociation from M3 receptors of bronchial smooth muscle (dissociation half-life around 35 hours). Reduces vagal tone, relaxes bronchial muscle and suppresses mucus hypersecretion. The 24-hour duration allows once-daily dosing. Inhaled systemic absorption is low (about 33% of dose), with most of the drug excreted unchanged in urine.

Safety

Contraindications

  • Hypersensitivity to tiotropium, atropine, ipratropium
  • Angle-closure glaucoma (relative)
  • Symptomatic prostatic hyperplasia with urinary retention (relative)

Serious adverse effects

  • Paradoxical bronchospasm
  • Acute angle-closure glaucoma if the drug reaches the eye
  • Acute urinary retention in older men
  • Anaphylactic reactions

Common adverse effects

  • Dry mouth
  • Constipation
  • Throat irritation
  • Cough immediately after inhalation
  • Headache

Pregnancy: can you take Tiotropium?

AEMPS summary of product characteristics (section 4.6): data on tiotropium use in pregnant women are very limited. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity at clinically relevant doses. As a precaution, it is preferable to avoid tiotropium during pregnancy.

Breastfeeding: can you take Tiotropium?

Probably compatible. Hale L3. Inhaled systemic absorption is low. AEMPS advises an individual decision in breastfeeding.

Calculate RIDFull profile on NIH LactMed ↗

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Practical notes

Timing and administration

Inhale once daily at the same time using the HandiHaler (powder) or Respimat (soft mist). A physician or pharmacist should demonstrate technique before first use. Rinse the mouth with water after each dose to reduce dryness and candidiasis. Does not replace short-acting bronchodilators during a flare.
Label mentions4 mentions

Verbatim lines from the interaction sections, in the language of the label

From this drug’s label

  • antihistaminesclass named in the label
    «Concomitant Respiratory Medications: SPIRIVA RESPIMAT has been used concomitantly with short-acting and long-acting sympathomimetic (beta-agonists) bronchodilators, methylxanthines, oral and inhaled…»

    FDA, section 7 · Open on DailyMed

  • corticosteroidesclass named in the label
    «Aunque no se han llevado a cabo estudios formales de interacción con otros fármacos, bromuro de tiotropio polvo para inhalación ha sido utilizado conjuntamente con otros medicamentos sin evidencia…»

    AEMPS, section 4.5 · Open on CIMA

  • simpaticomiméticosclass named in the label
    «Aunque no se han llevado a cabo estudios formales de interacción con otros fármacos, bromuro de tiotropio polvo para inhalación ha sido utilizado conjuntamente con otros medicamentos sin evidencia…»

    AEMPS, section 4.5 · Open on CIMA

  • sympathomimeticsclass named in the label
    «Concomitant Respiratory Medications: SPIRIVA RESPIMAT has been used concomitantly with short-acting and long-acting sympathomimetic (beta-agonists) bronchodilators, methylxanthines, oral and inhaled…»

    FDA, section 7 · Open on DailyMed

Check interaction with another drug

Opens the checker prefilled with this drug. Pick the second one from your regimen.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Frequently asked

What is Tiotropium used for?

Tiotropium is evaluated for the following indications with varying evidence strength: Asthma (evidence tier A), Severe asthma (evidence tier A), Chronic obstructive pulmonary disease (evidence tier A). See the full indication matrix with dosing and citations above on this page.

What are the side effects of Tiotropium?

Common side effects of Tiotropium (≥ 1 in 100): Dry mouth, Constipation, Throat irritation, Cough immediately after inhalation, Headache. See the Safety section for uncommon and serious reactions.

Is Tiotropium safe during pregnancy?

AEMPS summary of product characteristics (section 4.6): data on tiotropium use in pregnant women are very limited. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity at clinically relevant doses. As a precaution, it is preferable to avoid tiotropium during pregnancy.

Is Tiotropium compatible with breastfeeding?

Probably compatible. Hale L3. Inhaled systemic absorption is low. AEMPS advises an individual decision in breastfeeding.

Who should not take Tiotropium?

Tiotropium is contraindicated in: Hypersensitivity to tiotropium, atropine, ipratropium; Angle-closure glaucoma (relative); Symptomatic prostatic hyperplasia with urinary retention (relative). Full list in the Safety section.

Official sources

Direct links to regulator labels. Open in a new tab.

Other drugs in this group

Aclidinium, Beclomethasone dipropionate, Budesonide, Budesonide/formoterol, Fluticasone propionate, Mometasone, Salbutamol (Albuterol), Fluticasone